News

Join NCI for a webinar discussing the opportunity to license or co-develop a potential therapeutic treatment for COVID-19. SARS-CoV-2 infects the host via its spike (S) protein, which contains a receptor binding domain (RBD) that binds to an angiotensin converting enzyme 2 (ACE2) receptor on human
Join AUTM for the Essentials of Academic Technology Transfer Virtual Course. Attendees will receive a deeper understanding of the fundamental goals and processes of technology transfer. The course walks through the basic skills and resources needed to evaluate inventions and negotiate license
Louis Staudt, M.D., Ph.D. was recently awarded the Career Achievement Award, which recognizes ten or more years in HHS and dedication and loyalty to the Department. Dr. Staudt is the Chief of the Lymphoid Malignancies Branch at NCI. Dr. Staudt pioneered the use of gene expression profiling to